Remimazolam versus propofol anesthesia and thinking problems after aortic arch surgery
Compares remimazolam and propofol anesthesia for memory and thinking changes after aortic arch surgery.
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 80 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 30 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Remimazolam Besylate
- propofol
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are scheduled for surgery to replace all or part of the aortic arch, the curved top part of the main artery. It compares two anaesthesia drugs, remimazolam and propofol, and their effects on memory and thinking after surgery.
- Age
- 19 years or older
- Sex
- All sexes
- Disease stage
- Aortic arch disease needing total or partial aortic arch replacement. The surgery plans to stop blood flow or use special blood flow to the brain to protect it. Emergency surgery cannot join.
- Earlier treatment
- People who take opioids or benzodiazepines over a long time cannot join.
Main reasons for not taking part
- Existing problems with memory or thinking (MMSE score <24)
- Bleeding in the brain or stroke in the previous 3 months
- Allergy to remimazolam or other benzodiazepines, or past alcohol or drug abuse
- Severe liver disease (Child-Pugh class C) or kidney failure needing dialysis
- Emergency surgery or acute aortic dissection (a sudden tear in the main artery wall)
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adults aged 19 years or older
- Patients scheduled to undergo total or partial aortic arch replacement for aortic arch disease, with planned circulatory arrest and/or selective cerebral perfusion as a cerebral protection strategy during surgery
Who cannot take part
- Acute cerebral hemorrhage or cerebral infarction within the previous 3 months
- Pre-existing cognitive impairment, defined as Mini-Mental State Examination (MMSE) score <24
- History of hypersensitivity to remimazolam or other benzodiazepines
- History of alcohol or substance abuse
- Severe hepatic impairment (Child-Pugh class C)
- Acute or chronic renal failure requiring dialysis Emergency surgery or acute aortic dissection
- Chronic use of opioids or benzodiazepines
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to compare remimazolam- and propofol-based anesthesia for their effects on postoperative cognitive dysfunction in patients undergoing aortic arch surgery. These procedures involve a substantial risk of cerebral ischemia and reperfusion injury, which may contribute to postoperative cognitive decline. Although experimental studies have suggested potential neuroprotective effects of remimazolam, clinical evidence in patients undergoing high-risk aortic arch surgery remains limited. This prospective, randomized controlled trial will compare the incidence of postoperative cognitive dysfunction between patients receiving remimazolam- or propofol-based anesthesia. In addition, changes in circulating neuroinflammatory and neuronal injury biomarkers will be evaluated to explore the potential mechanisms underlying any neuroprotective effect of remimazolam. The findings may provide clinical evidence to guide anesthetic selection and improve neurological outcomes in patients undergoing aortic arch surgery.
The 2 groups in the trial
- Remimazolam groupTreatment being tested
Remimazolam Besylate (2mg/mL)
Treatment: Remimazolam Besylate
- Propofol groupTreatment being tested
Propofol (20mg/mL)
Treatment: propofol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery: A Randomized Controlled Trial
- Plain-language title
- Remimazolam versus propofol anesthesia and thinking problems after aortic arch surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 29 October 2026